MetaCap

Regencell Bioscience Holdings Limited Company Profile

NASDAQ: RGCHealth Care Medicinal Chemicals and Botanical Products USD

7.35-0.28 (-3.67%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Regencell Bioscience at a glance

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a Medicinal Chemicals and Botanical Products company in the Health Care sector headquartered in Causeway Bay, Hong Kong. Regencell Bioscience is led by Mr. Yat-Gai Au and employs about 10 people. The company's shares have traded publicly since 2021.

At a market capitalization of $3.64 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001829667, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Regencell Bioscience do?

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Business description based on the company's public filings.

Company information

Legal name
Regencell Bioscience Holdings Limited
Ticker
NASDAQ: RGC
Industry
Medicinal Chemicals and Botanical Products
CEO
Mr. Yat-Gai Au
Employees
10
Headquarters
Chinachem Leighton Plaza, Causeway Bay, Hong Kong
Phone
852 2155 0823
IPO year
2021
SEC CIK
0001829667

Companies similar to Regencell Bioscience

RGC peer companies
CompanyPrice% ChgMarket capCompare
DFTXDefinium Therapeutics Inc.36.90+7.96%$4.96Bvs RGC
TRLVTrulieve Cannabis Corp. Subordinate Voting Shares10.67+2.89%$2.05Bvs RGC
CRONCronos Group Inc.3.23+0.31%$1.19Bvs RGC
TLRYTilray Brands Inc.3.54-1.39%$523.15Mvs RGC
GLASGlass House Brands Inc. Subordinate Voting Shares4.26-3.40%$401.47Mvs RGC
CGCCanopy Growth Corporation0.8271-2.33%$371.62Mvs RGC
OBIOOrchestra BioMed Holdings Inc.5.95+3.84%$357.63Mvs RGC
SNDLSNDL Inc.1.220.00%$300.27Mvs RGC

Related